Impact of Primary Tumour Location and Early Tumour Shrinkage on Outcomes in Patients with RAS Wild-Type Metastatic Colorectal Cancer Following First-Line FOLFIRI Plus Panitumumab

OBJECTIVE: Data from a trial of first-line panitumumab plus FOLFIRI (folinic acid, infusional 5-fluorouracil and irinotecan) in metastatic colorectal cancer were retrospectively analysed to investigate the effects of primary tumour location and early tumour shrinkage on outcomes. METHODS: Patients w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs R D
Main Authors: Köhne, Claus-Henning, Karthaus, Meinolf, Mineur, Laurent, Thaler, Josef, Van den Eynde, Marc, Gallego, Javier, Koukakis, Reija, Berkhout, Marloes, Hofheinz, Ralf-Dieter
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738356/
https://ncbi.nlm.nih.gov/pubmed/31300973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0278-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados